Comprehensive Study and Future Growth in the Liver Diseases Therapeutics Market Scope: Key Innovations, Market Overview, Drivers, Size, Share and Growth Forecast 2024-2031 | Merck & Co. Inc., Novartis AG, Sanofi S.A, Pfizer Inc

The global liver diseases therapeutics market is estimated to be valued at US$ 17.0 billion in 2023 and is expected to exhibit a CAGR of 9.8% during the forecast period (2023-2030).

Market Overview:

Liver diseases have become a serious cause for concern among consumers worldwide. The therapeutics market provides a variety of drugs to treat acute and chronic conditions of the liver including hepatitis, fatty liver disease, cirrhosis and liver cancer. These drugs assist in improving liver function and regeneration.

Market Dynamics:

The liver diseases therapeutics market is primarily driven by the increasing prevalence of liver diseases globally. As per estimates by the World Health Organization (WHO), over 1.2 million people die each year due to hepatitis alone. Moreover, overweight and obesity have led to a surge in non-alcoholic fatty liver disease (NAFLD) cases. Approximately one-fourth of the world's population suffers from NAFLD. New product launches and increasing research and development activities by key players have also propelled market growth. Various pharmaceutical companies are focusing on developing novel drug molecules to effectively treat advanced liver conditions.

Request Exclusive Sample Copy of the Report at: - https://www.coherentmarketinsights.com/insight/request-sample/3809

List of TOP Players in Market Report are: -

◘ Astellas Pharma Inc.
◘ Bristol-Myers Squibb
◘ Gilead Sciences
◘ Glaxosmithkline Plc
◘ F. Hoffmann-La Roche Ltd.
◘ Merck & Co. Inc.
◘ Novartis AG
◘ Sanofi S.A
◘ Pfizer Inc.
◘ Takeda Pharmaceutical
◘ Valeant Pharmaceuticals
◘ Watson Pharmaceuticals Inc.
◘ Theratechnologies Inc.
◘ Alnylam Pharmaceuticals Inc.
◘ Protagonist Therapeutics Inc.
◘ Dicerna Pharmaceuticals Inc.
◘ Endo International
◘ Provectus Biopharmaceuticals Inc.
◘ MAX BioPharma Inc.

Note: Major Players are sorted in no particular order.

Market Detailed Segmentation:

Liver Diseases Therapeutics Market, Therapy Type: Anti-Rejection Drugs/Immunosuppressant, Chemotherapy Drugs, Targeted therapy, Vaccines, Anti-Viral Drugs, Immunoglobulin's, Corticosteroids
Liver Diseases Therapeutics Market, By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Market Drivers for Liver Diseases Therapeutics Market:

Increasing Prevalence of Liver Diseases:

Liver diseases such as hepatitis, fatty liver disease, alcoholic liver disease, autoimmune liver diseases, liver cancer have been on a rise across the globe. Factors such as chronic alcohol abuse, smoking, obesity, poor diet, genotype are significantly contributing to increasing prevalence of liver diseases. Increasing cases of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) due to growing obesity epidemic is a major concern. According to some estimates nearly 1 billion people globally have NAFLD. This growing patient pool is driving the demand for effective therapeutics to manage liver diseases.

Buy This Premium Report and Get Upto 25 % OFF: https://www.coherentmarketinsights.com/insight/buy-now/3809

Rising Healthcare Expenditure in Emerging Economies:

Countries such as China, India, Brazil are witnessing rapid economic growth and increasing disposable incomes. This has led to rise in healthcare spending in these markets. Governments as well as private players are investing heavily in modernizing healthcare infrastructure and services. Liver diseases pose a major health burden in these regions due to various socio-economic factors. Increased spending on diagnostics, drugs and treatment for liver diseases is boosting the growth of liver diseases therapeutics market in emerging economies.

Market Restrain for Liver Diseases Therapeutics Market:

Patent Cliff and Expiry of Blockbuster Drugs:

Key drugs that were top revenue generators for companies in liver disease therapeutics market such as Seretide/Advair (AstraZeneca), Lipitor (Pfizer) are going off-patent leading to patent cliff. Also, many anti-viral drugs used for treating hepatitis C are expected to lose patent protection over the next few years thereby becoming low-cost generics. This will significantly reduce profit margins for companies in this market. Generic competition could also erode the market share of some major blockbuster brands hampering the overall market growth.

Market Opportunity for Liver Diseases Therapeutics Market:

Immuno-oncology Therapies for Liver Cancer:

Liver cancer has low survival rates due to late stage diagnosis and lack of effective treatments. Immuno-oncology is an emerging area that is showing promise for treatment of liver cancer. Checkpoint inhibitors and other immunotherapies are being evaluated for liver cancer that can potentially improve treatment outcomes. Success of such therapies in clinical trials will open lucrative opportunities for drug developers in this market. Combination therapies using immunotherapies along with other therapeutic modalities is also a key area of focus. This presents a multi-billion-dollar commercial opportunity over the coming decade.

Market Trend for Liver Diseases Therapeutics Market:

Increasing Adoption of Personalized/Precision Medicine:

With advances in understanding of disease pathogenesis at molecular level, focus is shifting to developing personalized treatment approaches. Genetic testing helps in predictive, preventive and personalized care of liver diseases. Pharmacogenomics aids in selection of appropriate drug and dosage based on patient's genetic profile. Companies are developing companion diagnostics and collaborating with diagnostic firms to deliver personalized liver care. This trend will significantly grow in future and aid in delivering better treatment outcomes. It will also help reduce trial and error approach to therapies benefitting both patients and pharmaceutical industry.

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/3809

Furthermore, the years considered for the study are as follows:

Historical data - 2016-2022
The base year for estimation - is 2022
Estimated Year - 2024
Forecast period** - 2024 to 2031

This Liver Diseases Therapeutics Market Research/Analysis Report Contains Answers to your following Questions:

◈What are the current global trends in the Liver Diseases Therapeutics market, and will the market experience an increase or decrease in demand in the upcoming years?

◈ What is the expected demand for various product types within the Liver Diseases Therapeutics market, and what are the emerging Market applications and trends?

◈ What are the projections for the global Liver Diseases Therapeutics Market in terms of capacity, production, production value, cost, profit, market share, supply, consumption, import, and export?

◈ How will strategic developments shape the Market trajectory in the medium to long term?

◈ What factors contribute to the final price of Liver Diseases Therapeutics , and what are the raw materials used in its manufacturing?

◈ What is the market's growth potential, particularly with the increasing adoption of Liver Diseases Therapeutics in mining?

◈ What is the current and 2022 value of the global market, and who are the leading companies in this market?

◈ What recent Market trends can be leveraged to create additional revenue streams?

◈ What entry strategies, economic impact mitigation measures, and marketing channels should be considered for the Liver Diseases Therapeutics Market?

Summarized Extracts from TOC of Market Study

Chapter 1 Liver Diseases Therapeutics Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of Liver Diseases Therapeutics

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the Liver Diseases Therapeutics industry

1.4 Methodology of The Study

1.5 Research Data Source

Chapter 2 Executive Summary

Chapter 3 Industry Chain Analysis

Chapter 4 Market, by Type

Chapter 5 Market, by Application

Chapter 6 Market Analysis by Regions

Chapter 7 North America Market Analysis by Countries

Chapter 8 Europe Liver Diseases Therapeutics Market Analysis by Countries

Chapter 9 Asia Pacific Liver Diseases Therapeutics Market Analysis by Countries

Chapter 10 Middle East and Africa Liver Diseases Therapeutics Market Analysis by Countries

Chapter 11 South America Liver Diseases Therapeutics Market Analysis by Countries

Chapter 12 Competitive Landscape

Chapter 13 Industry Outlook

Chapter 14 Market Forecast

Chapter 15 New Project Feasibility Analysis

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.